MedTrace Logo

Evaluation of PTB Screening in ANC in Lusaka, Zambia

NCT02053129 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 5033

Last updated 2017-09-15

No results posted yet for this study

Summary

This is a pilot pulmonary TB screening program done in three antenatal care clinics in Lusaka, Zambia to determine the prevalence of culture-confirmed pulmonary tuberculosis and to determine the sensitivity and specificity of symptom-based TB screening.

Conditions

  • Pulmonary Tuberculosis

Interventions

OTHER

TB screening Questionnaire

All subjects will be screened with the questionnaire which assesses TB symptoms.

OTHER

Sputum smear and culture (only in HIV negative women who are symptomatic)

specimens for sputum microscopy and culture collected and processed in accordance with WHO TB Infection Control Guidelines

Sponsors & Collaborators

  • Centre for Infectious Disease Research in Zambia

    collaborator OTHER

  • University of North Carolina, Chapel Hill

    lead OTHER

Principal Investigators

  • Stewart Reid, MD · Centre for Infectious Disease Research in Zambia

  • Nzali Kancheya, MMED, MPH · Centre for Infectious Disease Research in Zambia

  • Michael Saag, MD · Professor, University of Alabama

  • German Henostroza, MD · Centre for Infectious Disease Research in Zambia

  • Annika Kruuner, MD · Centre for Infectious Disease Research in Zambia

Study Design

Allocation
RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
99 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-11-30
Primary Completion
2012-10-31
Completion
2013-12-31

Countries

  • Zambia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02053129 on ClinicalTrials.gov